Immunogenicity of tumors alkylated with cyclohexyl-, benzyl-. or 2,4-dinitrophenylmethacrylate.
D015127:9,10-Dimethyl-1,2-benzanthracene; D000179:Acrylates / Q000494:pharmacology*; D000230:Adenocarcinoma / Q000276:immunology; D000477:Alkylating Agents / Q000494:pharmacology*; D000818:Animals; D000917:Antibody Formation / Q000187:drug effects*; D000951:Antigens, Neoplasm; D001593:Benzyl Compounds / Q000494:pharmacology; D001943:Breast Neoplasms / Q000276:immunology; D004136:Dinitrobenzenes / Q000494:pharmacology; D005260:Female; D006801:Humans; D008689:Methacrylates / Q000494:pharmacology*; D051379:Mice; D008809:Mice, Inbred C3H; D009362:Neoplasm Metastasis; D009368:Neoplasm Transplantation; D009374:Neoplasms, Experimental / Q000139:chemically induced / Q000276:immunology*; D014184:Transplantation, Homologous
D000179:Acrylates; D000477:Alkylating Agents; D000951:Antigens, Neoplasm; D001593:Benzyl Compounds; D004136:Dinitrobenzenes; D008689:Methacrylates; C013507:2,4-dinitrophenylmethacrylate; D015127:9,10-Dimethyl-1,2-benzanthracene